Article
Single-agent Foxo1 inhibition normalizes glycemia and induces gut β-like cells in…
medRxiv · 2022 · Lee, Y.-K.; Nie, Y.; Diaz, B.; Sultana, N.; Kitamoto, T.; Du, W.; Leibel, R.; Accili, D.; Belvedere, S.
Key facts
| Title | Single-agent Foxo1 inhibition normalizes glycemia and induces gut β-like cells in streptozotocin-diabetic mice |
|---|---|
| First author | Lee, Y.-K.; Nie, Y.; Diaz, B.; Sultana, N.; Kitamoto, T.; Du, W.; Leibel, R.; Accili, D.; Belvedere, S. |
| Journal | medRxiv |
| Published | Mar 27, 2022 |
| DOI | 10.1101/2022.03.26.485929 |
| Devices mentioned | K012205, K893117, K951537, K963500, K964004, K964630, K971276, K984006, K990649, K991242 |
| Product codes mentioned | CFR, CGA, NBW, JJH, JRR, MVU, OOI |
At a glance
- 10–99 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1